Skip to content

Effects of Perioperative Intravenous Dexamethasone on Pain in Out Patient Knee Surgery

Effects of Perioperative Intravenous Dexamethasone on Pain in Out Patient Knee Surgery

Status
Terminated
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01149616
Enrollment
82
Registered
2010-06-23
Start date
2009-12-31
Completion date
2012-12-31
Last updated
2017-07-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nausea, Post Operative Pain

Brief summary

The purpose of the study is to determine the opiate sparing effects of intravenously administered dexamethasone in outpatient knee surgery. Dexamethasone is a glucocorticoid with well known antiemetic effects. However, the analgesic effects of dexamethasone have not been adequately researched. Following surgery, patients are typically discharged home with PO opiates to manage post-operative pain. The investigators believe that by using VAS (Visual Analog Scale) for Pain the investigators can show that a single dose of dexamethasone can reduce pain scales and opiate consumption post-operatively, on Post Operative Day (POD 1) when compared to placebo.

Detailed description

Findings of Modest improvement in pain scores and postoperative nausea at 24 hours with Dexamethasone

Interventions

DRUGDexamethasone 8mg iv x1

Dexamethasone 8mg iv x1

DRUGplacebo

2 ml normal saline IV x1

Sponsors

Beth Israel Deaconess Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Adult patients undergoing ambulatory knee arthroscopy surgery * Must provide phone contact number and agree to phone followup on post operative day 1

Exclusion criteria

* Patients with major systemic disease * Allergy or intolerance to study drug

Design outcomes

Primary

MeasureTime frameDescription
Post Operative VAS Pain Scale24 hoursPatients were instructed to select a number between zero and ten to indicate the degree of pain they experience (zero being no pain and ten being the worst pain they could imagine). Therefore, ten is worse than zero.

Secondary

MeasureTime frameDescription
Amount of Postop Narcotic Usage24 hoursPatients were requested to record the number of prescribed oral analgesic (oxycodone 5 mg/aceteminophen 325 mg) tablets taken for the first 24 hours following discharge
Postop Nausea24 hoursNRS scale 0-10 for nausea. Zero indicates no nausea, Ten indicates the worst nausea imagined.

Countries

United States

Participant flow

Recruitment details

2010

Participants by arm

ArmCount
Intervention
Dexamethasone 8mg iv x 1 Dexamethasone 8mg iv x1: Dexamethasone 8mg iv x1
41
Placebo
placebo placebo: placebo administered IV x1
41
Total82

Baseline characteristics

CharacteristicPlaceboTotalIntervention
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
41 Participants82 Participants41 Participants
Race and Ethnicity Not Collected0 Participants
Region of Enrollment
United States
41 participants82 participants41 participants
Sex: Female, Male
Female
16 Participants31 Participants15 Participants
Sex: Female, Male
Male
25 Participants51 Participants26 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 410 / 41
other
Total, other adverse events
0 / 410 / 41
serious
Total, serious adverse events
0 / 410 / 41

Outcome results

Primary

Post Operative VAS Pain Scale

Patients were instructed to select a number between zero and ten to indicate the degree of pain they experience (zero being no pain and ten being the worst pain they could imagine). Therefore, ten is worse than zero.

Time frame: 24 hours

ArmMeasureValue (MEAN)Dispersion
InterventionPost Operative VAS Pain Scale1.88 units on a scaleStandard Deviation 0.3
PlaceboPost Operative VAS Pain Scale3.73 units on a scaleStandard Deviation 0.5
p-value: 0.007ANOVA
Secondary

Amount of Postop Narcotic Usage

Patients were requested to record the number of prescribed oral analgesic (oxycodone 5 mg/aceteminophen 325 mg) tablets taken for the first 24 hours following discharge

Time frame: 24 hours

ArmMeasureValue (MEDIAN)
InterventionAmount of Postop Narcotic Usage1 number of tablets
PlaceboAmount of Postop Narcotic Usage2 number of tablets
p-value: 0.006ANOVA
Secondary

Postop Nausea

NRS scale 0-10 for nausea. Zero indicates no nausea, Ten indicates the worst nausea imagined.

Time frame: 24 hours

ArmMeasureValue (MEAN)
InterventionPostop Nausea0 units on a scale
PlaceboPostop Nausea0 units on a scale
p-value: 0.05ANOVA

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026